Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Feasibility of monitoring clopidogrel resistance with flow cytometric analysis of platelet vasodilator stimulated phosphoprotein phosphorylation].

Li G, Luo Y, Luo Y, Lin T, Fan X, Liang L, Xie H, Huang J.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Mar;34(3):434-7. Chinese.

2.
3.

[Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].

Morel O, Viellard C, Faure A, Jesel L, Ohlmann P, Desprez D, Chauvin M, Roul G, Grunebaum L, Bareiss P.

Ann Cardiol Angeiol (Paris). 2007 Jan;56(1):21-9. French.

PMID:
17343035
4.

Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry.

von Beckerath N, Sibbing D, Jawansky S, Braun S, Morath T, Vogt W, Schömig A, Kastrati A.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):46-52. doi: 10.1097/MBC.0b013e328332dbd4.

PMID:
19823079
5.

Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events.

Bonello L, Paganelli F, Arpin-Bornet M, Auquier P, Sampol J, Dignat-George F, Barragan P, Camoin-Jau L.

J Thromb Haemost. 2007 Aug;5(8):1630-6. Epub 2007 May 7.

6.

Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.

Stellbaum C, Ayral Y, Morguet A, Schultheiss HP, Rauch U.

Cardiovasc Revasc Med. 2012 May-Jun;13(3):159-66. doi: 10.1016/j.carrev.2012.02.009. Epub 2012 Apr 14.

PMID:
22503564
7.

Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.

Tsantes A, Ikonomidis I, Papadakis I, Kottaridi C, Tsante A, Kalamara E, Kardoulaki A, Kopterides P, Kapsimali V, Karakitsos P, Lekakis J, Travlou A.

Platelets. 2012;23(6):481-9. doi: 10.3109/09537104.2012.689037. Epub 2012 May 30.

PMID:
22646492
8.

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay.

Abtan J, Silvain J, Kerneis M, O'Connor SA, Barthélémy O, Vignalou JB, Beygui F, Brugier D, Collet JP, Montalescot G.

Thromb Haemost. 2013 Nov;110(5):1055-64. doi: 10.1160/TH13-03-0203. Epub 2013 Aug 8.

PMID:
23925438
9.

Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.

Metzler H, Prüller F, Münch A, Primus G, Kainz J, Hödl R, Rehak P.

Eur J Anaesthesiol. 2010 Feb;27(2):138-45. doi: 10.1097/EJA.0b013e32832eb521.

PMID:
19593147
10.

Platelet VASP phosphorylation assessment in clopidogrel-treated patients: lack of agreement between Western blot and flow cytometry.

Hezard N, Metz D, Garnotel R, Simon G, Mace C, Koebel P, Nguyen P.

Platelets. 2005 Dec;16(8):474-81.

PMID:
16323337
11.

Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).

Cuisset T, Grosdidier C, Loundou AD, Quilici J, Loosveld M, Camoin L, Pankert M, Beguin S, Lambert M, Morange PE, Bonnet JL, Alessi MC.

JACC Cardiovasc Interv. 2013 Aug;6(8):854-63. doi: 10.1016/j.jcin.2013.04.009.

12.

Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.

Freynhofer MK, Brozovic I, Bruno V, Farhan S, Vogel B, Jakl G, Willheim M, Hübl W, Wojta J, Huber K.

Thromb Haemost. 2011 Aug;106(2):230-9. doi: 10.1160/TH11-02-0077. Epub 2011 May 26.

PMID:
21614416
13.

Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12 -inhibition after ticagrelor intake.

Hobl EL, Jilma B, Derhaschnig U, Schoergenhofer C, Schwameis M, Jilma-Stohlawetz P.

Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):385-8. doi: 10.1002/cyto.b.21119. Epub 2013 Aug 26.

14.

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.

Koessler J, Kobsar AL, Rajkovic MS, Schafer A, Flierl U, Pfoertsch S, Bauersachs J, Steigerwald U, Rechner AR, Walter U.

Platelets. 2011;22(1):20-7. doi: 10.3109/09537104.2010.514967. Epub 2010 Sep 27.

PMID:
20873965
15.

A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.

Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ.

Thromb Haemost. 2008 Jan;99(1):215-22. doi: 10.1160/TH07-09-0555.

PMID:
18217157
16.

Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.

Aradi D, Magyarlaki T, Tokés-Füzesi M, Rideg O, Vorobcsuk A, Komócsi A.

Platelets. 2010;21(7):563-70. doi: 10.3109/09537104.2010.494742.

PMID:
20642320
17.

Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition.

Jakubowski JA, Bourguet N, Boulay-Moine D, Sugidachi A, Yamaguchi S, Barragan P, Zhou C, Moulard M.

Thromb Haemost. 2012 Feb;107(2):388-95. doi: 10.1160/TH11-04-0282. Epub 2011 Dec 21.

PMID:
22186965
18.

Reproducibility and standardized reporting of the vasodilator-stimulated phosphoprotein phosphorylation assay.

Siller-Matula JM, Panzer S, Jilma B.

Platelets. 2008 Nov;19(7):551-4. doi: 10.1080/09537100802272634.

PMID:
18979368
19.

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.

Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F.

J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11. doi: 10.1016/j.jacc.2007.12.044.

20.

Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading.

Kim IS, Jeong YH, Tantry US, Park Y, Lee DH, Bliden KP, Koh JS, Park JR, Jang JS, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S, Gurbel PA.

Am Heart J. 2013 Jul;166(1):95-103. doi: 10.1016/j.ahj.2013.03.030. Epub 2013 May 6.

PMID:
23816027

Supplemental Content

Support Center